CPHI - שווי מתואם לחוב ומזומנים China Pharma Holdings

China Pharma Holdings (CPHI) is a Chinese holding company expanding the production of psychotropic drugs and generics by upgrading capacities and leveraging its pricing power. Simultaneously, the business relies on the production of vitamins, where profitability is dictated by government tenders and a lack of product uniqueness. Current margins are stabilizing due to steady demand for basic medicines. This chart reflects the current market value of 30.48.

The geopolitical dependence of China Pharma Holdings (CPHI) on relations between Beijing and Washington directly impacts the investment attractiveness and market valuation of the issuer's assets. The current enterprise value aggregates market capitalization and net debt to determine the actual acquisition price of the business, while any sharp deviations on the chart signal increased risks for the long-term investor.